PTrana Meditama Metropolitan Tbk (ISX:SAME) Short-Term Debt: Rp897,259 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ISX:SAME PT Sarana Meditama Metropolitan Tbk ISX:SAME
65 GF Score
Price Rp320.00
GF Value Rp354.65
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is PTrana Meditama Metropolitan Tbk Short-Term Debt?

PTrana Meditama Metropolitan Tbk ISX:SAME +3.90% 65 Short-Term Debt is Rp897,259 Mil as of Jun. 2026. GuruFocus rates ISX:SAME with a GF Score™ of 65/100 and a GF Value™ of Rp354.65 (Modestly Undervalued). The stock has 4 warning signs investors should review.

PTrana Meditama Metropolitan Tbk's Short-Term Debt for the quarter that ended in Jun. 2026 was Rp897,259 Mil.

PTrana Meditama Metropolitan Tbk's quarterly Short-Term Debt increased from Dec. 2025 (Rp588,473 Mil) to Mar. 2026 (Rp682,239 Mil) and increased from Mar. 2026 (Rp682,239 Mil) to Jun. 2026 (Rp897,259 Mil).

PTrana Meditama Metropolitan Tbk's annual Short-Term Debt increased from Dec. 2023 (Rp277,640 Mil) to Dec. 2024 (Rp373,878 Mil) and increased from Dec. 2024 (Rp373,878 Mil) to Dec. 2025 (Rp588,473 Mil).

PTrana Meditama Metropolitan Tbk Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

PTrana Meditama Metropolitan Tbk Short-Term Debt Related Terms

PTrana Meditama Metropolitan Tbk Short-Term Debt Historical Data

* Premium members only.

The historical data trend for PTrana Meditama Metropolitan Tbk's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PTrana Meditama Metropolitan Tbk Short-Term Debt Chart

PTrana Meditama Metropolitan Tbk Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Short-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 15,493.26 89,404.89 277,639.51 373,878.39 588,473.43

PTrana Meditama Metropolitan Tbk Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 502,077.02 560,677.13 588,473.43 682,239.01 897,259.36
ISX:SAME
65GF Score
PT Sarana Meditama Metropolitan Tbk ISX:SAME
Short-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Short-Term Debt →
What does a Short-Term Debt of Rp897,259 Mil mean?
PTrana Meditama Metropolitan Tbk (ISX:SAME) has a Short-Term Debt of Rp897,259 Mil as of Jun. 2026.
Is PTrana Meditama Metropolitan Tbk's Short-Term Debt too high?
PTrana Meditama Metropolitan Tbk's current Short-Term Debt is Rp897,259 Mil. Overall, PTrana Meditama Metropolitan Tbk has a GF Score™ of 65/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PTrana Meditama Metropolitan Tbk's Short-Term Debt compare to HCA and THC?
PTrana Meditama Metropolitan Tbk's Short-Term Debt of Rp897,259 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Short-Term Debt for a Healthcare Providers & Services company?
A good Short-Term Debt depends on the Healthcare Providers & Services industry context. However, Short-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Short-Term Debt mean?
A high Short-Term Debt can signal that a stock is expensive relative to its fundamentals. PTrana Meditama Metropolitan Tbk's current Short-Term Debt is Rp897,259 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PTrana Meditama Metropolitan Tbk stock overvalued right now?
Based on GuruFocus' analysis, PTrana Meditama Metropolitan Tbk (ISX:SAME) is currently considered Modestly Undervalued. The stock's GF Value™ is Rp354.65, compared to a current price of Rp320.00 — trading 9.8% below its estimated fair value. The current Short-Term Debt is Rp897,259 Mil. PTrana Meditama Metropolitan Tbk's overall GF Score™ is 65/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Short-Term Debt calculated?
Short-Term Debt is calculated from a company's financial statements. For PTrana Meditama Metropolitan Tbk (ISX:SAME), the current Short-Term Debt is Rp897,259 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PTrana Meditama Metropolitan Tbk (ISX:SAME) Overvalued in 2026?

Based on GuruFocus' analysis, PTrana Meditama Metropolitan Tbk stock appears to be undervalued. The current stock price of Rp320.00 is trading 9.8% below its estimated GF Value™ of Rp354.65. GuruFocus considers PTrana Meditama Metropolitan Tbk to be Modestly Undervalued.

Key valuation signals for ISX:SAME:

  • Short-Term Debt: Rp897,259 Mil
  • GF Value™: Rp354.65 vs. price of Rp320.00 (9.8% below fair value)
  • GF Score™: 65/100 with 4 warning signs

No single metric tells the full story. See the ISX:SAME stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

PTrana Meditama Metropolitan Tbk Business Description

Address Jalan Pulomas Barat VI No. 20, RS EMC Pulomas, Kayu Putih, Pulogadung, Jakarta Timur, Jakarta, IDN, 13210
PT Sarana Meditama Metropolitan Tbk is engaged in managing hospitals. Its hospitals are operated under the brand name Omni Hospital. The company manages and evaluates its business based on its geographic location consisting of Omni Pulomas, Omni Alam Sutera, Omni Cikarang, OMNI Pekayon, and others. It operates in Banten, DKI Jakarta, and West Java.
65GF Score

Get the complete analysis for ISX:SAME

Short-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Rp320.00
Price
Rp354.65
GF Value